Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Simon Njenga"'
Autor:
Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P C Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E Kip, Gerard J Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 9, p e0004880 (2016)
BACKGROUND:SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India,
Externí odkaz:
https://doaj.org/article/8f00c7ff8e114d8499c8306afaf2b491
Autor:
Ahmed M, Musa, Jane, Mbui, Rezika, Mohammed, Joseph, Olobo, Koert, Ritmeijer, Gabriel, Alcoba, Gina, Muthoni Ouattara, Thaddaeus, Egondi, Prossy, Nakanwagi, Truphosa, Omollo, Monique, Wasunna, Luka, Verrest, Thomas P C, Dorlo, Brima, Musa Younis, Ali, Nour, Elmukashfi, Taha Ahmed Elmukashfi, Ahmed, Ismail Omer Haroun, Eltahir A G, Khalil, Simon, Njenga, Helina, Fikre, Tigist, Mekonnen, Dagnew, Mersha, Kasaye, Sisay, Patrick, Sagaki, Jorge, Alvar, Alexandra, Solomos, Fabiana, Alves
Publikováno v:
Clinical Infectious Diseases. 76:e1177-e1185
Background This study aimed to determine whether paromomycin plus miltefosine (PM/MF) is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary visceral leishmaniasis in eastern Africa. Methods An open-label, phase 3,
Autor:
Simon Njenga, G. Kirigi, Asrat Hailu, Ahmed Eleojo Musa, Monique Wasunna, Joseph Olobo, Thomas P. C. Dorlo, Manica Balasegaram, Eltahir A G Khalil, Mats O. Karlsson, Anke E. Kip, Brima M. Younis, Jos H. Beijnen, Fabiana Alves, Sally Ellis
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background: Low efficacy of miltefosine in the treatment of visceral leishmaniasis was recently observed in Eastern Africa. Objectives: To describe the pharmacokinetics and establish a pharmacokinetic/pharmacodynamic relationship for miltefosine in E
Autor:
Manica Balasegaram, Neal Alexander, Anke E. Kip, Mohammed Hassan Sharaf Ali, Eltahir A G Khalil, Gerard J. Schoone, Simon Njenga, Sally Ellis, Susan Wells, Thomas P. C. Dorlo, Robert Kimutai, Monique Wasunna, Joseph Olobo, Asrat Hailu, Fabiana Alves, Raymond Omollo, Brima Musa, Nathalie Strub Wourgaft, Mohammed Yasein Elamin, G. Kirigi, Ahmed Eleojo Musa, Rashid Juma, Tansy Edwards
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 9, p e0004880 (2016)
PLoS Neglected Tropical Diseases, 10(9), 1. Public Library of Science
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 10(9), 1. Public Library of Science
PLoS Neglected Tropical Diseases
Background SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India,
HLA-A and HLA-B in Kenya, Africa: Allele frequencies and identification of HLA-B*1567 and HLA-B*4426
Autor:
Ma Luo, S. Ramdahin, Francis A. Plummer, Joanne Embree, Job B. Bwayo, S. Pan, Simon Njenga, Mary Cheang, Robert C. Brunham, Jeckoniah O. Ndinya-Achola, Xiaojuan Mao, T. Stuart
Publikováno v:
Tissue Antigens. 59:370-380
HLA-A and HLA-B alleles of a population from Kenya, Africa were examined by sequencing exon 2 and exon 3 DNA and typing using a Taxonomy-based Sequence-analysis (TBSA) method. Extensive diversities were observed at both HLA-A and HLA-B loci in this p
Autor:
Nico J. D. Nagelkerke, Simon Njenga, Jeckoniah O. Ndinya-Achola, Francis A. Plummer, HO Pamba, Joanne Embree, Patrick M. Nyange, Job J. Bwayo
Publikováno v:
The Pediatric Infectious Disease Journal. 20:397-403
Background. Reference lymphocyte subset values for African children are lacking. This study documents these values as well as their alterations associated with perinatal and postnatal HIV-1 transmission and with protection from HIV-1 infection. Metho
Autor:
Joanne Embree, Susie Ramhadin, Francis A. Plummer, Kelly S. MacDonald, Jose Castillo, JO Ndinya-Achola, Julius Oyug, Nico Nagelkerke, Brian H. Barber, Simon Njenga, Job J. Bwayo
Publikováno v:
The Journal of Infectious Diseases. 183:503-506
Certain HLAs may, in part, account for differences in human immunodeficiency virus type 1 (HIV-1) susceptibility by presenting conserved immunogenic epitopes for T cell recognition. The HLA supertype A2/6802 is associated with decreased susceptibilit
Autor:
Job J. Bwayo, Brian H. Barber, Kelly S. MacDonald, Joanne Embree, Nico J. D. Nagelkerke, Jeckoniah O. Ndinya-Achola, Irene Ngatia, Francis A. Plummer, Simon Njenga, Zeena Mohammed
Publikováno v:
The Journal of Infectious Diseases. 177:551-556
Major histocompatibility complex (MHC) gene products are expressed on human immunodeficiency virus (HIV)-infected cells and incorporated into the lipid envelope of HIV virions. Macaques immunized with human MHC gene products are protected from simian
Autor:
Simon Njenga, Job J. Bwayo, Francis A. Plummer, Joanne Embree, Nicolaas J. D. Nagelkerke, Mark A. Luscher, Gregory Choy, Kelly S. MacDonald, Brian H. Barber
Publikováno v:
AIDS Research and Human Retroviruses. 14:99-107
Searching for mechanisms of natural resistance to HIV infection with which to guide HIV vaccine design, we have examined antibody responses to HLA class I antigens in children of HIV-1-infected mothers. Anti-HLA antibodies are known to block HIV infe
Autor:
Manica Balasegaram, Joke van Peteghem, Roberto de la Tour, Mark Riongoita, Rashid Juma, G. Kirigi, Simon Njenga, Adrian Laussermayer, François Chappuis, Raymond Omollo, Jane Mbui, Monique Wasunna
Publikováno v:
PLoS Neglected Tropical Diseases
PLOS Neglected Tropical Diseases, Vol. 7, No 9 (2013) P. e2441
PLoS Neglected Tropical Diseases, Vol 7, Iss 9, p e2441 (2013)
PLOS Neglected Tropical Diseases, Vol. 7, No 9 (2013) P. e2441
PLoS Neglected Tropical Diseases, Vol 7, Iss 9, p e2441 (2013)
Background Visceral leishmaniasis (VL) is a systemic parasitic disease that is fatal unless treated. In Kenya, national VL guidelines rely on microscopic examination of spleen aspirate to confirm diagnosis. As this procedure is invasive, it cannot be